Immunmodulation of serum in orthopaedic trauma

Journal of Trauma - Injury, Infection and Critical Care

Volumn 67, Issue 3, 2009, Pages 624-627

  Reikeras, Olav ^a   Sun, Jingbo ^a   Wang, Jacob E ^a   Foster, Simon J ^b   Bastian, Daniel ^a   Aasen, Ansgar O ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Immune response; Inflammatory cytokines; Postoperative serum; Trauma

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNOMODULATION; LEUKOCYTE FUNCTION; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TOTAL HIP PROSTHESIS; BIOLOGICAL MODEL; BLOOD; CELLULAR IMMUNITY; CULTURE TECHNIQUE; DRUG EFFECT; HIP ARTHROPLASTY; HIP INJURY; IMMUNOLOGY; LEUKOCYTE; MIDDLE AGED; PHYSIOLOGY; SERUM BACTERICIDAL ACTIVITY;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD BACTERICIDAL ACTIVITY; CELL CULTURE TECHNIQUES; FEMALE; HIP INJURIES; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70449092021     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181813581     Document Type: Article

References (33)

1. Majetschak M, Flach R, Heukamp T, et al. Regulation of whole blood tumor necrosis factor production upon endotoxin stimulation after severe blunt trauma. J Trauma. 1997;43:880-887.
2. Majetschak M, Flach R, Kreuzfelder E, et al. The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med. 1999;27:313-318.
3. Heagy W, Hansen C, Nieman K, et al. Impaired ex vivo lipopolysaccharide- stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients. Shock. 2000;14:271-276.
4. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993;119:771-778.
5. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988;318:1481-1486.
6. Kieft H, Hoepelman AI, Zhou W, Rozenberg-Arska M, Struyvenberg A, Verhoef J. The sepsis syndrome in a Dutch university hospital. Clinical observations. Arch Intern Med. 1993;153:2241-2247.
7. Marks JD, Marks CB, Luce JM, et al. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis. 1990;141:94-97.
8. Wang JE, Dahle MK, Yndestad A, et al. Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat. Crit Care Med. 2000;32:546-552.
9. Wang JE, Solberg R, Okkenhaug C, Jorgensen PF, Krohn CD, Aasen AO. Cytokine modulation in experimental endotoxemia: characterization of an ex vivo whole blood model. Eur Surg Res. 2000;32:65-73.
10. Timmerman CP, Mattsson E, Martinez-Martinez L, et al. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect Immun. 1993;61:4167-4172.
11. Nau R, Eiffert H. Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflam- mation and outcome in sepsis and meningitis. Clin Microbiol Rev. 2002;15:95-110.
12. Flohe SB, Bangen JM, Flohe S, Agrawal H, Bergmann K, Schade FU. Origin of immunomodulation after soft tissue trauma: potential involvement of extracellular heat-shock proteins. Shock. 2007;27:494-502.
13. Wang JE, Warris A, Ellingsen EA, et al. Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun. 2001;69:2402-2406.
14. Foster SJ. Analysis of the autolysins of Bacillus subtilis 168 during vegetative growth and differentiation by using renaturing polyacrylamide gel electrophoresis. J Bacteriol. 1992;174:464-470.
15. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg. 1997;226:450-458.
16. Neidhardt R, Keel M, Steckholzer U, et al. Relationship of interleukin- 10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma. 1997;42:863-870.
17. Dimofte G, Alexander A, Carlson G, Little R, Irving M. TNF alpha and IL-6 involvement in surgical trauma. II. In vitro cytokine production. Rev Med Chir Soc Med Nat Iasi. 2001;105:493-498.
18. Desborough. The stress response to trauma and surgery. Br J Anaesth. 2000;85:109-117.
19. Wichmann MW, Ayala A, Chaudry IH. Severe depression of host immune functions following closed-bone fracture, soft-tissue trauma, and hemorrhagic shock. Crit Care Med. 1998;26:1372-1378.
20. Kong SE, Blennerhassett LR, Heel KA, McCauley RD, Hall JC. Ischaemia- reperfusion injury to the intestine. Aust N Z J Surg. 1998;68:554-561.
21. Moore FA. The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg. 1999;178:449-453.
22. Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC. Postinjury multiple organ failure: a bimodal phenomenon. J Trauma. 1996;40501-40510.
23. Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injury. J Am Coll Surg. 2001;193:237-244.
24. Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420:885-891.
25. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol. 1999;163:3920-3927.
26. Nagata Y, Takahashi N, Davis RJ, Todokoro K. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood. 1998;92:1859-1869.
27. Takeuchi O, Akira S. Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol. 2005;1:625-635.
28. Rabehi L, Irinopoulou T, Cholley B, Haeffner-Cavaillon N, Carreno MP. Gram-positive and gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways. Infect Immun. 2001;69:4590-4599.
29. Dziarski R. Peptidoglycan recognition proteins (PGRPs). Mol Immunol. 2004;40:877-886.
30. Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev. 2005;204:27-42.
31. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock. 2006;26:430-437.
32. Johnson GB, Brunn GJ, Platt JL. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through toll-like receptor 4. J Immunol. 2004;172:20-24.
33. Kitchens RL, Thompson PA. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res. 2005;11:225-229.